Carvana's Upbeat Q2 Revenue and bluebird bio's Bullish View Drive Momentum
- July 19th, 2023
- 472 views
Shares of Carvana Co. (NYSE: CVNA) experienced a significant surge of over 20% in pre-market trading following the company's announcement of its best quarter ever for adjusted EBITDA and total gross profit per unit.
Carvana reported second-quarter 2023 revenue of $2.97 billion, surpassing consensus estimates of $2.59 billion. Notably, the total gross profit per unit (GPU) showed an impressive year-over-year increase of 94%, reaching $6,520.
The company also revealed that its adjusted EBITDA for Q2 reached $155 million. Moreover, Carvana expressed confidence in achieving positive adjusted EBITDA for the second consecutive quarter in the third quarter of 2023.
$CVNA was trading at $48.00 in pre-market, up $8.20 (+20.60%).
In other news, BofA Securities has upgraded bluebird bio, Inc. (Nasdaq: BLUE) from Neutral to Buy and raised the price target from $6 to $10.
With $BLUE closing at $3.15 on Tuesday, the upgraded price target indicates a potential upside of $6.85 or approximately 217.46%, according to the financial advisory firm's view.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
DOT, DoW, DHS Join Forces to Protect Southern Border Airspace
October 16th, 2026FTC Sues Ticket Broker Over Unlawful Tactics Used to Buy Millions of Tickets to Popular Live Events
October 15th, 2026October 15th, 2026FDA Approves First Treatment for Certain People With BCG-Unresponsive Bladder Cancer
October 14th, 2026U.S. Treasury Announces Record Enforcement Actions Against Bank of America
October 14th, 2026
Member Login